Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05394428 · ClinicalTrials.gov registry record
A Multi Center Study of Sexual Toxicities After Radiotherapy
A clinical trial of Malignant Neoplasms, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 300
- Enrollment target
- 3
- Study locations
NCT05394428: Recruiting study of Malignant Neoplasms, sponsored by Icahn School of Medicine at Mount Sinai.
NCT05394428 is a study of Malignant Neoplasms that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 300 participants, below the 3,343-participant average among 3 other Malignant Neoplasms trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05394428, a study of Malignant Neoplasms, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research is to understand how radiotherapy and other cancer treatments impact sexual function in female cancer patients and to try to answer a question about why some patients who receive radiotherapy are more likely to have side effects than others. The results of this study may improve our understanding of why sexual side effects occur and in turn develop predictive models and biomarkers of sexual side effects and other side effects that may impact sexual function. The results of this study may also lead to improvements in the techniques used to deliver radiotherapy or the development of interventions that will prevent or reduce sexual side effects and improve quality of life for female patients with cancer.
Primary Outcome
Establish a cohort of patients with female sexual organs receiving radiotherapy
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (3)
Georgia
- Emory University - Atlanta
New York
- Icahn School of Medicine at Mount Sinai - New York
Texas
- M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-10-04 |
| Est. Completion | 2026-08-31 |
What NCT05394428 shows while recruiting
NCT05394428 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 3,343-participant average among 3 other Malignant Neoplasms trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Malignant Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT05394428 reports a single indexed study location in Georgia, New York, Texas.
Frequently Asked Questions
What is clinical trial NCT05394428 about?
NCT05394428 is a clinical study titled "A Multi Center Study of Sexual Toxicities After Radiotherapy". The purpose of this research is to understand how radiotherapy and other cancer treatments impact sexual function in female cancer patients and to try to answer a question about why some patients who receive radiotherapy are more likely to have side effects than others. The results of this study may...
What is the current status of trial NCT05394428?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2022-10-04. Estimated completion is 2026-08-31.
What conditions does trial NCT05394428 study?
This clinical trial studies the following conditions: Malignant Neoplasms.
What interventions are being tested in trial NCT05394428?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05394428?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05394428 being conducted?
This trial has 3 study locations across Georgia, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RECRUITING
-
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
RECRUITING · Phase 1
-
Community Cancer Centers Pilot Patient Survey
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI